Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not need to be taken with food. Unlike some medicines that require a meal to protect the stomach or aid absorption, tirzepatide injections can be given at any time of day, regardless of whether you have eaten. That said, the decision about when and how you take it is still worth thinking through carefully, because your routine and meal timing will shape how manageable the side effects are, especially in the early weeks. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber reviews your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who start Mounjaro arrive at the same question: does it matter whether I eat before or after I inject? The short answer, per the Mounjaro Summary of Product Characteristics available on the electronic Medicines Compendium, is no, absorption is not affected by food. The injection goes under the skin; it does not pass through your digestive system the way a tablet does.
The decision that does matter is what you eat in general while on treatment. Tirzepatide slows the rate at which food leaves the stomach. Rich, fatty or very large meals sit there longer than usual, which is why some people find heavy food uncomfortable when they are adjusting to the medicine. If you are unsure whether you should eat before taking Mounjaro, a lighter meal is less likely to cause discomfort than a large one, whatever side of the injection it falls on.
The bigger practical question our prescribers hear regularly is about food choices rather than injection timing. If you want a clear steer on what kinds of meals tend to work well, our guide to eating on Mounjaro goes through that in detail.
Nausea is the side effect most likely to make you revisit your injection schedule, and it is worth understanding why it happens. As the NHS tirzepatide medicines page explains, nausea, vomiting and indigestion are common especially in the early weeks or after a dose increase. Tirzepatide activates receptors in the brain's appetite-regulation centres as well as in the gut, and that central action is part of why some people feel queasy.
For many people, injecting in the evening means any nausea peaks overnight and has largely settled by morning. Others prefer a weekend morning so they can take things slowly if they need to. Neither is medically superior, the right time is the one you will stick to. A simple check that takes under a minute: look at your diary for the next four weeks and pick the day and rough time that has the fewest clashes. Consistency protects you from missed doses more than any particular slot does.
What tends to worsen nausea regardless of timing is eating a large, fatty meal in the hours after injecting. If you notice a pattern, keeping meals lighter on injection day is a reasonable practical adjustment. Anything beyond that (changing your dose schedule or timing because of persistent side effects) is a conversation for your prescriber, not a self-managed tweak. You can find more about what to avoid and why on our page about foods to steer clear of on Mounjaro.
Consistency matters more than any particular moment you choose. Mounjaro is a once-weekly injection; the medicine stays active in your system across the full week, so injecting at 7pm on a Tuesday versus 9am on a Wednesday makes no meaningful clinical difference provided you maintain a roughly seven-day gap. The Patient Information Leaflet (available with your pen and on the eMC) covers what to do if you miss a dose, always follow that guidance rather than guessing.
It is also worth thinking about the injection site alongside timing. Abdomen, thigh and upper arm are all suitable, and rotating between them keeps the tissue healthy. If you have questions about technique or are unsure about storage requirements, the leaflet inside your pen and your prescriber are the right first port of call. Questions about supplements, including whether something like creatine interacts with the medicine, also come up, our page on creatine and Mounjaro addresses that one specifically.
Some people also ask whether taking Mounjaro at all is, somehow, the easy way out. It is a fair question to sit with. For what it is worth, our page on whether Mounjaro is 'cheating' sets out the evidence-based perspective honestly, without cheerleading. What the medicine does not do is make food choices irrelevant, and if you are wondering whether you take Mounjaro with food, our dedicated page covers exactly that alongside why protein adequacy, hydration and fibre still matter throughout your treatment.
If you would like to explore whether tirzepatide is clinically suitable for you, a free consultation with one of our GPhC-registered prescribers is the place to start. They review your information the same day (a real clinician reads your answers, not a piece of software) and can discuss your specific circumstances including any questions about your diet and routine. Start your free consultation when you are ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.